<DOC>
	<DOCNO>NCT00037219</DOCNO>
	<brief_summary>Anidulafungin may effective treatment invasive Candida infection . The purpose study find balance dose tolerance effectiveness several dos treatment United States patient invasive candidiasis .</brief_summary>
	<brief_title>The Safety Effectiveness Intravenous Anidulafungin Treatment Patients With Invasive Candidiasis .</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Positive culture plus least one clinical sign symptom consistent invasive candidiasis preferably within 96 hour propose first dose study drug Life expectancy : great 72 hour Pregnant Females Treatment investigational drug ( ) within 4 week Hypersensitivity anidulafungin echinocandin therapy Hypersensitivity Tween 80 ( polysorbate 80 ) tartaric acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Anidulafungin</keyword>
	<keyword>Candidemia</keyword>
	<keyword>Invasive Candidiasis</keyword>
</DOC>